it is a study involving vitiligo patients, which will be treated by two separate topical medication followed by procedure with microneedling and NBUVB therapy which will result in darkening of vitiligo patches
Phase 2
- Registration Number
- CTRI/2024/04/065773
- Lead Sponsor
- mgm medical college and hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
A patient who voluntarily agreed and given consent to participate in the study.
A patient who has two or more non segmental, stable vitiligo lesions with similar degree of progression measuring 5cm2 or more present over the face, trunk or limbs.
All patients with vitiligo presenting to MGM medical college and hospital.
Exclusion Criteria
Local disease such as folliculitis.
Patient on anticoagulants and blood thinners
Keloidal tendencies
HIV, Hepatitis B or C, or otherwise
immunocompromised patient.
Unrealistic expectations of patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method